A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2013-10-25
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT01105286
- Locations
- 🇫🇷
LEO Pharma site, Nice, France
Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 31
- Registration Number
- NCT01083758
- Locations
- 🇺🇸
Rady Children's Hospital San Diego, San Diego, California, United States
🇺🇸Leavitt Medical Associates of Florida, Inc., Ormond Beach, Florida, United States
🇺🇸Peachtree Dermatology Associates, PC, Atlanta, Georgia, United States
Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
- Conditions
- First Posted Date
- 2010-01-20
- Last Posted Date
- 2014-02-19
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 724
- Registration Number
- NCT01052467
- Locations
- 🇩🇪
University Clinical Schleswig-Holstein, Campus Kiel, Kiel, Germany
A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2013-10-25
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT01043224
- Locations
- 🇫🇷
LEO Pharma site, Nice, France
LEO 29102 Cream in the Treatment of Atopic Dermatitis
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2019-10-14
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 183
- Registration Number
- NCT01037881
- Locations
- 🇨🇦
Windsor Clinical Research Inc., Windsor, Ontario, Canada
🇫🇮Helsinki University Central Hospital, Helsinki, Finland
🇩🇪Klinik und Poliklinik für Dermatologie, Universität Bonn, Bonn, Germany
Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea
- Conditions
- Interventions
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2020-03-31
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 401
- Registration Number
- NCT01025635
LEO 27847 - A Study in Healthy Male Subjects
- First Posted Date
- 2009-11-04
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 48
- Registration Number
- NCT01007383
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd., Leeds, United Kingdom
A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas
- First Posted Date
- 2009-11-04
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 40
- Registration Number
- NCT01007591
- Locations
- 🇫🇷
CHU Saint-Etienne Hôpital NOrd, Saint-Etienne, France
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
- Conditions
- Interventions
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2013-10-22
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 36
- Registration Number
- NCT01005823
- Locations
- 🇳🇱
PRA International, University Medical Centre, Groningen, Netherlands
Fucidin® Cream in the Treatment of Impetigo
- First Posted Date
- 2009-09-30
- Last Posted Date
- 2015-04-14
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 58
- Registration Number
- NCT00986856
- Locations
- 🇸🇪
Vårdcentrum Kungshöjd, Göteborg, Sweden
🇳🇴Institute of Internal Medicin, Haukeland University Hospital, Bergen, Norway